Global Hemorrhoid Treatment Market Size, Share, Trends, COVID-19 Impact & Growth Forecast Report – Segmented By Treatment Type (Drugs, Surgical Procedures, Non-surgical procedures), Device Type (Bipolar Probes, Cryotherapy Devices, Hemorrhoid Laser Probes, Sclerotherapy Injectors, Band Ligators, Others), Type (Internal Haemorrhoids, External Hemorrhoids), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), End-Use (Hospitals, Ambulatory surgical centers, Others) and Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) – Industrial Analysis From 2025 to 2033
Global Hemorrhoid Treatment Market Report Summary
The global hemorrhoid treatment market was valued at USD 802.73 million in 2024, is estimated to reach USD 849.29 million in 2025, and is projected to reach USD 1,333.34 million by 2033, growing at a CAGR of 5.8% during the forecast period from 2025 to 2033. The growth of the global hemorrhoid treatment market is primarily driven by the rising prevalence of hemorrhoids worldwide, increasing adoption of sedentary lifestyles, and growing incidence of constipation and obesity. Increasing awareness regarding hemorrhoid symptoms and available treatment options, along with expanding access to over-the-counter products, is further supporting market growth. Moreover, advancements in minimally invasive procedures and rising healthcare expenditure across emerging economies are improving treatment accessibility and contributing to sustained market expansion
Key Market Trends
- Increasing prevalence of hemorrhoids linked to sedentary lifestyles, obesity, and poor dietary habits.
- Growing preference for non-surgical and minimally invasive hemorrhoid treatment procedures.
- Rising availability and adoption of over-the-counter topical drugs and suppositories.
- Technological advancements in hemorrhoid treatment devices such as band ligators and laser probes.
- Expanding digital healthcare platforms and online pharmacies improving treatment access.
Segmental Insights
- Based on treatment type, the non-surgical procedures segment held the largest share of the global hemorrhoid treatment market in 2024. The dominance of this segment is attributed to the increasing adoption of procedures such as rubber band ligation, cryotherapy, infrared coagulation, and radiofrequency treatments that offer effective symptom relief with minimal recovery time.
- Based on device type, the band ligators segment dominated the global market in 2024. The segment’s leadership is driven by its high efficacy in treating internal and severe hemorrhoids, lower complication rates compared to hemorrhoidectomy, and widespread clinical acceptance.
- Based on type, the external hemorrhoids segment accounted for a significant share of the global hemorrhoid treatment market in 2024 due to its higher prevalence and symptom severity, which often requires medical intervention.
- Based on distribution channel, the hospital pharmacies segment led the market in 2024, supported by strong hospital-pharmaceutical collaborations and the availability of prescription-based treatments. Meanwhile, online pharmacies are expected to grow rapidly during the forecast period due to convenience, discounts, and increasing digital adoption.
- Based on end-use, the hospital segment held the dominant market share in 2024 owing to the availability of advanced treatment options, skilled healthcare professionals, and preference for hospital-based procedures for moderate to severe hemorrhoid cases.
Regional Insights
- The global hemorrhoid treatment market is experiencing steady growth across major regions, supported by rising disease prevalence, improved diagnosis rates, and expanding healthcare infrastructure.
- Europe dominated the global hemorrhoid treatment market in 2024, driven by high disease awareness, advanced healthcare systems, and increasing adoption of technologically advanced treatment devices.
- North America is expected to witness the fastest growth during the forecast period, supported by the strong presence of key market players, rising awareness campaigns, and increasing adoption of minimally invasive treatment options.
- The Asia Pacific region is anticipated to register significant growth over the forecast period due to rising healthcare expenditure, growing patient population, and increasing research activities focused on developing effective and affordable hemorrhoid treatments in countries such as China, India, and Japan.
Competitive Landscape
The global hemorrhoid treatment market is characterized by the presence of established medical device manufacturers and pharmaceutical companies focusing on innovation, product development, and minimally invasive treatment solutions. Leading players are investing in research and development to introduce advanced devices that reduce post-operative complications and recovery time. Strategic collaborations, clinical trials, and acquisitions are strengthening competitive positioning, while expanding product portfolios and improving distribution networks are enhancing global market reach. Prominent players in the global hemorrhoid treatment market include Boston Scientific Corporation, Medtronic Plc, Cook Medical, Integra LifeSciences, CONMED Corporation, Johnson & Johnson, Allergan, GlaxoSmithKline plc, Pfizer Inc., and Taro Pharmaceuticals.
Global Hemorrhoid Treatment Market Size
The global hemorrhoid treatment market size was valued at USD 802.73 million in 2024. The hemorrhoid treatment market size is expected to be valued at USD 849.29 million in 2025 and USD 1333.34 million by 2033, growing at a CAGR of 5.8% during the forecast period.
Hemorrhoids are also known as piles which are swollen veins in the anus and lower rectum. Hemorrhoids are similar to varicose veins, which can develop inside the rectum and are known as internal hemorrhoids. When developed under the skin around the anus called external hemorrhoids. The symptoms include pain or discomfort, itching, swelling, bleeding in case of external hemorrhoids, and painless bleeding, pain, and irritation in internal hemorrhoids.
MARKET DRIVERS
The growing prevalence of hemorrhoids globally among people is majorly contributing to the demand for hemorrhoid treatment worldwide, which is driving the global market growth.
According to a Medscape report in 2022, the prevalence of symptomatic hemorrhoids is estimated at 4.4% in the general population. It also stated that in the United States, up to one-third of the 10 million people with hemorrhoids seek medical treatment, resulting in 1.5 million prescriptions per year. The National Library of Medicine released an article regarding the outpatient survey at UoGCSH, Ethiopia, in 2021, where the results stated that the prevalence of hemorrhoids is higher in males than females. It also stated that constipation and overweight are found to increase the odds of having hemorrhoids. The increasing adoption of a sedentary lifestyle, which involves an unhealthy diet, is impacting people with obesity and constipation, leading to the prevalence of hemorrhoids seeking medical treatment. There is growing awareness among people regarding the medical condition of hemorrhoids and the availability of treatment options. All these factors enhance the adoption of hemorrhoid treatment, raising the global market growth.
The growing techno advancements in the healthcare industry are driving the global market revenue with innovative and minimally invasive procedures for treating hemorrhoids. The increasing investments by the market players in the research activities allow them to focus on developing innovative and effective treatment procedures that fuel the hemorrhoid treatment market share in the forecast period.
The growing government initiatives to spread awareness among the people regarding hemorrhoids and treatment options will provide market growth opportunities in the forecast period. The increasing healthcare expenditure worldwide due to emerging economies is expected to augment the hemorrhoid treatment market in the upcoming years. The rising availability of over-the-counter products for treating hemorrhoids supports the hemorrhoid treatment market. These OTC products are estimated to offer convenience and ease of access to the treatment, which enhances the growth of the hemorrhoid treatment market.
MARKET RESTRAINTS
The primary factor restraining the global hemorrhoid treatment market is the side effects associated with hemorrhoidectomy, including pain, bleeding, infection, fecal incontinence, and constipation, which are expected to hamper the global market expansion. The recovery time of the hemorrhoid surgery is expected to be 2 to 4 weeks. If the patient experiences pain or aches during the recovery period, this is expected to limit the adoption of hemorrhoid treatment. The presence of other alternative procedures, such as homeopathy, changing lifestyle, and diet, is expected to hinder the growth of the global hemorrhoid treatment market.
The need for awareness and skilled professionals for the treatment of hemorrhoids is challenging for the market expansion due to limited professionals for a huge number of patients. The availability of other treatment plans for hemorrhoid treatment, such as lifestyle changes with high fiber intake, is expected to impede the global market expansion by reducing the demand for hemorrhoid treatment products and services.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2024 to 2033 |
| Base Year | 2024 |
| Forecast Period | 2025 to 2033 |
| Segments Covered | By Treatment Type, Device Type, Type, Distribution Channel, End-Use, And Region. |
| Various Analyses Covered | Global, Regional & Country Level Analysis, Segment-Level Analysis; DROC, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, APAC, Latin America, Middle East & Africa |
| Market Leader Profiled | Boston Scientific Corporation, Medtronic Plc, Cook Medical, Integra LifeSciences, CONMED Corporation, Johnson & Johnson, Allergan, GlaxoSmithKline plc, Pfizer Inc., Taro Pharmaceuticals. |
SEGMENTAL ANALYSIS
By Treatment Type Insights
The non-surgical procedures segment held the largest market share in the global market. Cryotherapy, infrared coagulation, and radiofrequency are the most commonly used non-surgical approaches for the treatment of hemorrhoids.
The drugs segment has been gaining traction in recent years to avoid post-surgical pain, which is expected to grow steadily during the forecast period.
By Device Type Insights
The band ligators segment dominated the global hemorrhoid treatment market with a dominant market share and is expected to maintain its prominence with a significant CAGR in the forecast period. The increasing prevalence of hemorrhoids, growing research activities, and new product launches are enhancing the global market expansion. Band ligators offer better solutions for severe and internal hemorrhoids. Band ligators are effective and provide better outcomes, driving segment growth. According to a research study, Rubber band ligation versus hemorrhoidectomy for treatment of grade II-III hemorrhoids, the hemorrhoidectomy provides better symptom control but with more post-surgical complications, whereas very few complications are observed with band ligators.
By Type Insights
The external hemorrhoids segment dominated the global hemorrhoid treatment market due to its high prevalence globally. The internal hemorrhoids develop inside the rectum and are less common than the external hemorrhoids. In most cases, internal hemorrhoids are preferably treated with over-the-counter products.
By Distribution Channel Insights
The hospital pharmacies segment dominated global revenue with a significant market share. The government and the hospital pharmacies support hospitals, which mainly collaborate with pharmaceuticals, boosting the global market expansion.
Online pharmacies have gained traction in recent years due to people's widespread adoption of digital platforms worldwide. Online pharmacies are expected to have prominent growth during the forecast period due to the discounts, offers, and other benefits digital distributors provide.
By End-Use Insights
The hospital segment held the dominant market share in the global market revenue due to the presence of various services and advanced technological devices for the treatment of hemorrhoids. People highly prefer hospitals for treatment due to the presence of skilled healthcare professionals, which fuels the segment's growth by raising the global hemorrhoid treatment market share.
REGIONAL ANALYSIS
The European region dominated the global hemorrhoid market due to the rising prevalence of hemorrhoids. The presence of advanced healthcare infrastructure with technological advancements in hemorrhoid treatment devices and growing awareness among the people is enhancing early-stage detection, which supports hemorrhoid treatment by raising the global market value.
The North American region is expected to have the fastest growth during the forecast period due to significant market players and the disease's growing prevalence. The growing awareness among the people regarding the various treatment options due to the government initiatives fuels the regional market growth.
The growing healthcare expenditure in countries like Japan, China, and India is enhancing the expansion of the hemorrhoid treatment market in the Asia Pacific region during the forecast period. The increasing research activities to developing innovative, effective treatment procedures that will augment the future market growth.
KEY MARKET PLAYERS
Some of the companies that are playing a dominating role in the global market include
- Boston Scientific Corporation
- Medtronic Plc
- Cook Medical
- Integra LifeSciences
- CONMED Corporation
- Johnson & Johnson
- Allergan
- GlaxoSmithKline plc
- Pfizer Inc.
RECENT MARKET DEVELOPMENTS
- In June 2022, ProNova Partners, the U.S.-based mergers and acquisitions firm, was permitted to assist in selling all rights to manufacture and sell a patented, painless, non-invasive device to eliminate hemorrhoids.
- In May 2022, a clinical study was initiated with the title "Comparative Study on Endoscopic Treatments for Hemorrhoids: A Multicenter, Randomized Controlled Clinical Trail" and is expected to be completed by January 2025, sponsored by Fangyu Wang.
MARKET SEGMENTATION
This research report on the hemorrhoid treatment market has been segmented and sub-segmented based on the treatment type, device type, type, distribution channel, end-use, and region.
By Treatment Type
- Drugs
- Surgical Procedures
- Non-surgical procedures
By Device Type
- Cryotherapy Devices
- Bipolar Probes
- Hemorrhoid Laser Probes
- Band Ligators
- Sclerotherapy Injectors
- Others
By Type
- Internal Hemorrhoids
- External Hemorrhoids
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
By End-Use
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Frequently Asked Questions
What is the hemorrhoid treatment market?
The hemorrhoid treatment market includes products and procedures used to treat internal and external hemorrhoids, such as medications, minimally invasive procedures, and surgical interventions.
What are hemorrhoids?
Hemorrhoids are swollen and inflamed veins in the rectum or anus that cause symptoms such as pain, itching, bleeding, and discomfort during bowel movements.
What factors are driving the growth of the hemorrhoid treatment market?
Key drivers include rising prevalence of constipation, sedentary lifestyles, poor dietary habits, increasing geriatric population, and growing awareness of available treatment options.
What treatment types are available in the hemorrhoid treatment market?
Treatment options include topical creams and ointments, oral medications, rubber band ligation, sclerotherapy, infrared coagulation, and surgical procedures such as hemorrhoidectomy.
Which product segments dominate the hemorrhoid treatment market?
Over-the-counter creams, suppositories, wipes, and minimally invasive devices dominate the market due to ease of use and quick symptom relief.
What challenges does the hemorrhoid treatment market face?
Social stigma, delayed diagnosis, side effects of medications, and limited access to advanced treatment in developing regions are key challenges.
Which regions dominate the hemorrhoid treatment market?
North America and Europe dominate the market due to higher awareness and advanced healthcare infrastructure, while Asia-Pacific is expected to witness rapid growth.
What trends are shaping the hemorrhoid treatment market?
Key trends include increased adoption of non-surgical treatments, development of herbal and natural remedies, and improved diagnostic techniques.
What is the future outlook for the hemorrhoid treatment market?
The market is expected to grow steadily during the forecast period due to rising incidence, technological advancements, and improved patient awareness.
Who are the key players in the hemorrhoid treatment market?
The market includes pharmaceutical companies and medical device manufacturers offering medications, minimally invasive devices, and surgical solutions.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com